Nominations have opened for the Chief Allied Health Professions Awards creating an opportunity for allied health professionals to showcase their innovative and high quality respiratory work.

Healthcare professionals should raise awareness of the dangers of air pollution with patients with chronic respiratory and cardiovascular conditions, says a new Quality Standard on air pollution

A cross-party group of MPs has set out a range of tough measures to tackle tobacco dependency including raising the minimum age of sale for tobacco to prevent youngsters taking up the habit.

Regular e-cigarette use among young people remains low in Britain and has plateaued among adults, says a new report from Public Health England.

Registration is now open for the Primary Care Respiratory Academy 2019 Clinical, Commissioning and Pharmacy events.

It’s No Smoking Day 2019 on Wednesday March 13, the national health awareness day that encourages smokers to quit.

The UK has the highest asthma death rate for young people aged 10-24, compared with other wealthy countries. This is the finding of an international comparison of young people’s health conducted by the Nuffield Trust and the Association for Young People’s Health.

There is a danger that the debate around e-cigarettes will drown out the work needed to tackle tobacco dependency, warns a leading respiratory physician in a BMJ editorial.

PCRS has launched an online giving page where people can donate money to support our work to influence respiratory healthcare policy and campaign for improvements in respiratory care.

PCRS Executive member Dr Vince Mak, Consultant Physician in Respiratory Integrated Care at Imperial College Healthcare Trust, has been appointed Clinical Director of the London Respiratory Strategic Clinical Network (RSCN).

E-cigarettes are almost twice as effective as nicotine replacement treatments (NRT) at helping smokers to quit finds a new study published in the New England Journal of Medicine

The new five year GP contract has introduced some important changes to the respiratory QOF indicators, effective from April 2019 in England.

The NHS has been slow to respond to rapid advances in molecular diagnostics which with new treatments for lung cancer are leading to improvements in survival for patients.

Editor Dr Iain Small says:  “This issue takes a look at the past, the present and the future.